Survival outcomes and symptomatic central nervous system (CNS) metastasis in EGFR-mutant advanced non-small cell lung cancer without baseline CNS metastasis: Osimertinib vs. first-generation EGFR tyrosine kinase inhibitors
Titel:
Survival outcomes and symptomatic central nervous system (CNS) metastasis in EGFR-mutant advanced non-small cell lung cancer without baseline CNS metastasis: Osimertinib vs. first-generation EGFR tyrosine kinase inhibitors
Auteur:
Zhou, Yue Wang, Bo Qu, Jinghan Yu, Fan Zhao, Yang Li, Shuyan Zeng, Ya Yang, Xi Chu, Li Chu, Xiao Li, Yida Zou, Liqing Guo, Tiantian Ye, Luxi Liang, Fei Wang, Shengping Liu, Quan Ni, Jianjiao Zhu, Zhengfei